MedPath

interventions based on lifestyle modificatio

Not Applicable
Conditions
Polycystic ovary syndrome.
Disorders of other endocrine glands
E20-E35
Registration Number
IRCT2016092129909N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
220
Inclusion Criteria

Diagnosis of PCOS according to Rotterdam criteria
All participants are Iranian speakers and have the ability to read and write
Age between 18-40 years old
BMI > 25 kg / m² and < 38 kg / m²

Exclusion Criteria

chronic disease
Using insulin-sensitizing drugs;
Using contraceptive drugs
Using antihypertensive drugs
Using lipid lowering drugs
Using any hormonal drugs
Using any antidepressants
Special diets or exercise for weight loss in past 6 months
Participating in previous similar studies
Ovulation induction in the past year
Smoking or using alcohol
Mental disorders
History of any type of malignancy
Being pregnant
Lactation in the past year
Bleeding of unknown cause

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of Life Score in the Health Short Form Questionnaire (SF-36). Timepoint: 0-24 weeks. Method of measurement: The Short Form Health Survey(SF-36).;Quality of Life Score in Polycystic Ovary Syndrome Questionnaire (PCOSQ). Timepoint: 0--24 weeks. Method of measurement: Polycystic Ovary Syndrome Questionnaire (PCOSQ).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath